Estrella Immunopharma's total assets for Q2 2025 were $2.98M, an increase of 21.94% from the previous quarter. ESLA total liabilities were $9.08M for the fiscal quarter, a 112.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.